Correlation Between NextCure and MediciNova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextCure and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and MediciNova, you can compare the effects of market volatilities on NextCure and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and MediciNova.

Diversification Opportunities for NextCure and MediciNova

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between NextCure and MediciNova is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of NextCure i.e., NextCure and MediciNova go up and down completely randomly.

Pair Corralation between NextCure and MediciNova

Given the investment horizon of 90 days NextCure is expected to under-perform the MediciNova. In addition to that, NextCure is 1.69 times more volatile than MediciNova. It trades about -0.18 of its total potential returns per unit of risk. MediciNova is currently generating about -0.29 per unit of volatility. If you would invest  216.00  in MediciNova on October 20, 2024 and sell it today you would lose (33.00) from holding MediciNova or give up 15.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NextCure  vs.  MediciNova

 Performance 
       Timeline  
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
MediciNova 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

NextCure and MediciNova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextCure and MediciNova

The main advantage of trading using opposite NextCure and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.
The idea behind NextCure and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges